Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Lifeward Ltd. - Ordinary Shares (NQ: LFWD ) 3.070 -0.080 (-2.54%) Streaming Delayed Price Updated: 3:59 PM EDT, Sep 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Lifeward Ltd. - Ordinary Shares Lifeward Launches Direct Sales of AlterG Product Line in Germany September 24, 2024 Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward’s path to profitability From Lifeward, Inc. Via GlobeNewswire ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. September 12, 2024 Following approval by the shareholders and the Israel Companies Registrar, Lifeward has completed is rebranding initiative with a formal name change of the parent company in Israel From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research September 10, 2024 A past-president of the American Spinal Injury Association, Dr. Tansey brings Lifeward over 30 years of experience in research and treatment of spinal cord injuries as a practicing Physician,... From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury September 05, 2024 As part of the fundraising “Step Challenge”, ReWalk users in Germany completed 424,844 steps to raise 5,000 Euros for the European Spinal Cord Injury Federation (“ESCIF”) From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 04, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward Reports Second Quarter 2024 Financial Results August 15, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward to Report Second Quarter Financial Results on August 15, 2024 August 08, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire The 3 Best Robotic Exoskeleton Stocks to Buy Now July 27, 2024 The best Robotic Exoskeletons stocks are highly lucrative, given recent industry developments and growing product uptake. Via InvestorPlace Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors July 02, 2024 Jeff Dykan, who led Lifeward as Chairman of its Board through the past 15 years, has announced his intent to retire at the end of his current term From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO June 26, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Sidoti Events, LLC's Virtual June Small-Cap Conference June 11, 2024 Via ACCESSWIRE Lifeward to Present at Sidoti Virtual Investor Conference on June 12 June 04, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire LFWD Stock Earnings: Rewalk Robotics Beats EPS, Misses Revenue for Q1 2024 May 28, 2024 LFWD stock results show that Rewalk Robotics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. Via InvestorPlace Lifeward Reports First Quarter 2024 Financial Results May 15, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward to Report First Quarter Financial Results on May 15, 2024 May 07, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward Announces the Appointment of Mike Swinford to its Board of Directors April 19, 2024 Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business development From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton April 12, 2024 Finalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Unleashing the Underdogs: 3 Hidden Gems Set to Conquer the Market April 04, 2024 Dive into the success stories of these hidden gem stocks that will conquer the market as they transforming their respective industries. Via InvestorPlace Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate April 01, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward Announces Reverse Share Split March 13, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy March 08, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be March 01, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire ReWalk Robotics Q4 Earnings Miss Estimates, Issues FY24 Guidance February 27, 2024 ReWalk Robotics reports Q4 earnings below estimates, with revenue miss; forecasts lower-than-expected revenue for FY24. Via Benzinga Topics Earnings Exposures Financial Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results February 27, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 February 20, 2024 From ReWalk Robotics Ltd. (DBA Lifeward) Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.